Publication | Open Access
Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism
304
Citations
34
References
2005
Year
Protein SecretionProtein AssemblyAmyloid ProteinMolecular BiologyCytoskeletonProtein Phase SeparationAa AmyloidosisAlzheimer's DiseaseProtein FoldingDegenerative PathologyPrion DiseaseProtein MisfoldingProteomicsProtein FunctionBiochemistryBiomolecular EngineeringNeurodegenerative DiseasesDisease MechanismNatural SciencesBombyx MoriProtein EngineeringProtein FibrilsMedicine
Secondary, or amyloid protein A (AA), amyloidosis is a complication of chronic inflammatory diseases, both infectious and noninfectious. AA constitutes the insoluble fibrils, which are deposited in different organs, and is a major N-terminal part of the acute phase protein serum AA. It is not known why only some patients with chronic inflammation develop AA amyloidosis. Nucleation is a widely accepted mechanism in amyloidogenesis. Preformed amyloid-like fibrils act as nuclei in amyloid fibril formation in vitro, and AA amyloid fibrils and synthetic amyloid-like fibrils also may serve as seed for fibril formation in vivo. In addition to amyloid fibrils, there is a variety of similar nonmammalian protein fibrils with beta-pleated structure in nature. We studied three such naturally occurring protein fibrils: silk from Bombyx mori, Sup35 from Saccharomyces cerevisiae, and curli from Escherichia coli. Our results show that these protein fibrils exert amyloid-accelerating properties in the murine experimental AA amyloidosis, suggesting that such environment factors may be important risk factors in amyloidogenesis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1